Evidence map›Paper›PMID 42577907›Full record

ArticlePublic health challenges2026

Hepatitis C Micro-Elimination in a Deprived Coastal Town: Lessons From Blackpool.

Sarah E Blagden, Emma L MacFarlane, Dianne C Draper

Abstract read
In one paragraph

Article in Public health challenges, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Sarah E BlagdenBlackpool Researching Together (NIHR Blackpool Health Determinants Research Collaboration) Blackpool UK.ORCID https://orcid.org/0000-0003-2789-6655
Emma L MacFarlaneDelphi Medical Limited Blackpool UK.
Dianne C DraperPublic Health Directorate Blackpool UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Blackpool is the most deprived local authority district in England and consistently has one of the highest rates of hepatitis C virus (HCV) nationally. This study describes a multi-stakeholder approach to address low levels of HCV testing within drug and alcohol treatment services in Blackpool and evaluates the outcomes of this. Methods: This study is a rapid evaluation utilising the UK Health Security Agency's rapid evaluation model. Individual-level data were extracted from adult drug and alcohol treatment services in Blackpool for all clients accessing services between April 2024 and July 2025. Analysis consisted of descriptive statistics to determine testing and treatment outcomes against national HCV micro-elimination criteria and to describe the client population. Hypothesis testing was carried out to investigate differences between clients testing positive and negative, and binary logistic regression to identify factors associated with a positive HCV test. Results: Of 1294 clients attending services, 1071 had a valid HCV test result recorded during the period. Of these, 32 tested positive for active HCV infection (3%), >90% of whom initiated treatment. There was significantly greater heroin use, crack use and injecting behaviour amongst those testing positive. Injecting mediated the relationship with substance type and was the only factor independently associated with HCV infection. Conclusions: All micro-elimination criteria were met, and drug and alcohol services in Blackpool achieved micro-elimination. Moving forwards, services must sustain the culture changes that have embedded HCV testing within standard practice.

Indexed as

evaluationhepatitis Cmicro‐eliminationpeople who inject drugs

Identifiers

PMID42577907
PMCPMC13455540

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.